The only medical insurance “different name library” in the country was abandoned.

blob.png

Recently, the Tianjin Municipal Development and Reform Commission issued the "Tianjin Municipal Human Resources and Social Security Bureau to take the initiative to correct the behavior of medical insurance in the medical insurance payment work", the document pointed out that according to the reflection of some pharmaceutical manufacturers, the Tianjin Municipal Human Resources and Social Security Bureau issued in 2017 The notification of the publicity of information collection and the payment of medical insurance to the experts to review the relevant issues of the drug results, and the "Notice on the publicity of further drug information collection and medical insurance payment convergence expert evaluation results" did not include some of the drug manufacturers to produce "National Basic Medical Care" The drugs in the Insurance, Work Injury Insurance and Maternity Insurance Drug List are included in the scope of Tianjin medical insurance payment, which reduces the potential for purchasing and using these drugs at all levels and in various medical institutions in Tianjin, and hinders the fullness of the Tianjin medical and pharmaceutical market. competition.

blob.png

Therefore, the Tianjin Municipal Development and Reform Commission interviewed the Tianjin Human Resources and Social Security Bureau. Through detailed interpretation of the relevant provisions of the Anti-Monopoly Law and full communication, the Tianjin Municipal Human Resources and Social Security Bureau recently issued the "Ministry of Social Security and Social Security Bureau on the Docking 2017 Edition of the National Catalogue. The Notice on Relevant Issues stipulates that the future medical insurance payment shall be strictly implemented in accordance with the relevant provisions of the State. For the “National Drug Catalogue of 2017”, the requirements of the “National Drug Catalogue” are included in the scope of medical insurance payment, and enterprises can voluntarily fill in the medicines. After the information, free access to the city's medical and pharmaceutical market.

The Tianjin Municipal Development and Reform Commission recognized the Tianjin Human Resources and Social Security Bureau's approach and requested the Tianjin Human Resources and Social Security Bureau to seriously implement the "Opinions of the State Council on Establishing a Fair Competition Review System in the Construction of the Market System" in the future work. Issue [2016] No. 34), speed up the fair competition review, clean up the stock documents, review the incremental documents, and avoid similar problems.

This document means that the “different name library” of medical insurance with unique local characteristics that lasted for 12 years in Tianjin has gone to the end.

It is reported that Tianjin Medical Insurance “Different Name Library” was born in 2005. It is based on the results of centralized bidding/purchasing of the health department. It has a strict number of proportional control, expert review, and even joined the medical insurance and pharmaceutical companies to “re-negotiate again”. "The most important thing is that the pharmaceutical company is required to report the price after the winning bid, and if it is not the lowest price in the country, directly remove the different name library." In the pharmaceutical market in Tianjin, only the drugs that enter the medical insurance “different name library” can be reimbursed after the insured personnel use it. Even the national/Tianjin medical insurance target variety cannot be reimbursed.

Some analysts said that the Tianjin Human Resources and Social Security Bureau set up a management of the Tianjin Alien Library, which violated Article 37 of the Anti-Monopoly Law, "Administrative authorities must not abuse administrative power, and formulate provisions for excluding and restricting competition content." This has increased the entry barrier for drugs to enter the Tianjin market, restricting competition, which has led to corporate dissatisfaction, and only to the end of the company's report that led to its ultimate abolishment.

Vaccine For Rabies Prophylaxis

Travelers to areas where rabies is endemic may be at risk, especially if they are likely to come in contact with animals in areas where dog or other animal rabies is enzootic and immediate access to appropriate medical care is unlikely. Canine rabies remains highly endemic in certain areas of the world. Need for rabies preexposure vaccination depends on the nature of risk and associated level of potential exposure. preexposure vaccination based on local incidence of rabies in the country to be visited, availability of appropriate agents for rabies postexposure prophylaxis in that country, and intended activity and duration of stay

Vaccine For Rabies Prophylaxis,Rabies Prophylaxis Vaccine,Freeze Rabies Prophylaxis Vaccine,Freeze Vaccine For Rabies Prophylaxis

Changchun Zhuoyi Biological Co., Ltd , https://www.zhuoyibiological.com